On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...
For those with cancer, each day can be a climb of its own. That's why Missoula firefighters hit the stairs to raise money for ...
A lymphoma specialist who survived her own tumor surgery helps patients navigate the daunting decisions to be made.
Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...
News Medical on MSN2d
The CAR T Veteran: A Journey of Resilience, Remission, and AdvocacyLaurie Adami's experience with CAR T-cell therapy highlights its potential in treating Non-Hodgkin Lymphoma, emphasizing the ...
Caregiving can take many forms, often requiring a profound shift in daily life. While navigating a disease is an immense challenge for patients, managing the emotional, logistical and personal burdens ...
An international team of doctors led by Joshua Brody, MD, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer ...
Results of 3 trials revealed that omitting transplant did not impact progression or survival outcomes for pediatric, ...
Ann LaCasce, MD, MMSc, director of the Dana-Farber/Massachusetts General Brigham Fellowship in Hematology/Oncology, highlights the role of bispecific antibodies in lymphoma research.
World Cancer Day aims to raise awareness for the prevention, detection, and treatment of all kinds of cancers, with ...
Co., Inc. (NYSE: MRK) has initiated a pivotal Phase 3 clinical trial, waveLINE-010, to evaluate the efficacy of its investigational drug zilovertamab vedotin in treating patients with previously ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback